Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects

Clinical Biochemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles